Arbutus to Report First Quarter 2023 Financial Results and Provide Corporate Update
20 avr. 2023 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 20, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...